Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Integrin alpha 5 beta 1 Antibody (M200 (Volociximab)) - Chimeric - Azide and BSA Free, Novus Biologicals™
SDP

Rabbit Monoclonal Antibody has been used in 5 publications

Supplier:  Novus Biologicals NBP2526800.025MG

 View more versions of this product

Catalog No. NBP2526825


Only null left
Add to Cart

Description

Description

Integrin alpha 5 beta 1 Monoclonal specifically detects Integrin alpha 5 beta 1 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunofluorescence, CyTOF-ready, Block/Neutralize.
Specifications

Specifications

Integrin alpha 5 beta 1
Monoclonal
Unconjugated
PBS with 0.02% Proclin 300. with 0.02% Proclin 300
Rabbit
Protein A or G purified
RUO
The antibody binds to human alpha 5 beta 1 integrin with a Kd of 0.367 nM (determined by Biacore), an EC50 of 0.2 nM and an IC50 of 2.3 nM.
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
IgG
Flow Cytometry, ELISA, Immunohistochemistry, Blocking Assay, Immunofluorescence, CyTOF
M200 (Volociximab)
Flow Cytometry 1:10 - 1:1000, ELISA 1:100 - 1:2000, Immunohistochemistry 1:10 - 1:500, Blocking/Neutralizing 50 - 200 molar excess, Immunofluorescence 1:10 - 1:500, CyTOF-ready
ITGA5
Heterodimeric alpha 5 Beta 1 Fc fusion protein
0.025 mg
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.